Probucol disuccinate
CAS No. 216168-45-5
Probucol disuccinate( —— )
Catalog No. M18242 CAS No. 216168-45-5
Probucol is an anti-hyperlipidemic drug initially developed in the treatment of coronary artery disease by lowering the level of cholesterol in the bloodstream by increasing the rate of LDL catabolism.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 38 | In Stock |
|
| 10MG | 60 | In Stock |
|
| 25MG | 102 | In Stock |
|
| 50MG | 147 | In Stock |
|
| 100MG | 225 | In Stock |
|
| 200MG | 342 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameProbucol disuccinate
-
NoteResearch use only, not for human use.
-
Brief DescriptionProbucol is an anti-hyperlipidemic drug initially developed in the treatment of coronary artery disease by lowering the level of cholesterol in the bloodstream by increasing the rate of LDL catabolism.
-
DescriptionProbucol is an anti-hyperlipidemic drug initially developed in the treatment of coronary artery disease by lowering the level of cholesterol in the bloodstream by increasing the rate of LDL catabolism.
-
In VitroProbucol Disuccinate is a derivative of Probucol.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorLDL
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number216168-45-5
-
Formula Weight716.99
-
Molecular FormulaC39H56O8S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)(C)c1cc(cc(c1OC(=O)CCC(=O)O)C(C)(C)C)SC(C)(C)Sc1cc(c(c(c1)C(C)(C)C)OC(=O)CCC(=O)O)C(C)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yamamoto A,et al.A uniqe antilipidemic drug--probucol. J Atheroscler Thromb. 2008 Dec;15(6):304-5. Epub 2008 Dec 11.
molnova catalog
related products
-
Rebaudioside F
Rebaudioside F is a natural product.
-
FGIN-1-43
FGIN-1-43 is a potent and specific ligand for the mitochondrial DBI receptor.
-
GRGDSP TFA
GRGDSP, a synthetic linear RGD peptide, is an integrin inhibitor which can be used to modify the surface of cardiovascular implants such as vascular grafts to promote endothelialization.
Cart
sales@molnova.com